Abstract: An intraocular lens to be implanted into the capsular bag after ablation of the crystalline lens includes a central optical portion and a haptic portion including haptic members arranged on the periphery of the optical part and for positioning the intraocular lens in the capsular bag. On the one hand, the posterior surface of the optical portion includes a sharp ridge at the peripheral edge and, on the other hand, the posterior surface of the haptic members includes a proximal area in the vicinity of the peripheral edge of the optical portion, each proximal area including at least one tooth extending substantially along the entire width of each haptic member, the tooth or teeth having a sharp edge that becomes serrated in the posterior capsule in order to limit the migration of the epithelial cells of the haptic members towards the optical portion.
Abstract: The invention relates to a holding device for an intraocular lens, characterized in that the holding device has an elongated support member open to the bottom, on which an elongated holding rail for holding the lens is disposed. The invention also relates to an injector device for an intraocular lens as well as to a packaging and transport device for the intraocular lens. Furthermore, the invention relates to a method for packaging an intraocular lens as well as to a method for loading an intraocular lens into an injector device.
Abstract: The invention relates to an intraocular lens comprising at least one pharmaceutically-acceptable photochromic polymer that enables all or part of the intraocular lens to change colour reversibly when exposed to light.
Type:
Grant
Filed:
January 6, 2006
Date of Patent:
August 6, 2013
Assignee:
Carl Zeiss Meditec SAS
Inventors:
Pascal Bernard, Marc Dolatkhani, Anne Pagnoux, Christophe Hupin
Abstract: An intraocular implant adapted to come in contact with the aqueous humor comprises a hydrophilic polymer having a predetermined water content for implantation in an eye, an effective quantity of a medicated product for treatment of the eye being dispersed in the mass of the hydrophilic polymer of the implant, the association of the hydrophilic polymer and the dispersed medicated product being adapted to release the product progressively into the aqueous humor.
Type:
Grant
Filed:
March 25, 2003
Date of Patent:
May 10, 2011
Assignee:
Carl Zeiss Meditec SAS
Inventors:
Jean-Marc Aiache, Gilbert Serpin, Said El Meski, Philippe Tourrette